NBC Securities’s Takeda Pharmaceutical TAK Stock Holding History

NBC Securities’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$841K	Buy	52,488 +4,955	+10%	+$82K	0.06%	352
2026 Q1	$880K	Sell	47,533 -6,876	-13%	-$121K	0.07%	312
2025 Q4	$848K	Sell	54,409 -49	-0.1%	-$701	0.06%	318
2025 Q3	$797K	Sell	54,458 -988	-2%	-$14.7K	0.06%	340
2025 Q2	$857K	Sell	55,446 -206	-0.4%	-$3.04K	0.07%	308
2025 Q1	$827K	Buy	55,652 +55,601	+109,022%	+$779K	0.07%	291
2024 Q4	$682	Sell	51 -51,768	-100%	-$711K	0.06%	338
2024 Q3	$736K	Buy	51,819 +105	+0.2%	+$1.49K	0.06%	337
2024 Q2	$669K	Buy	51,714 +8,175	+19%	+$108K	0.06%	340
2024 Q1	$614K	Buy	43,539 +765	+2%	+$11.1K	0.06%	379
2023 Q4	$610K	Buy	42,774 +1,440	+3%	+$20.4K	0.06%	345
2023 Q3	$639K	Buy	+41,334	New	+$640K	0.07%	303

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

NBC Securities's TAK Position: Q2 2026 in Review

NBC Securities increased its Takeda Pharmaceutical (TAK) stake by 10% in Q2 2026, buying an estimated $82K and bringing the position to 52,488 shares worth $841K. The position accounts for 0.06% of the portfolio, ranked #352.

NBC Securities first reported a position in TAK in Q3 2023 and has held it in 12 quarters since. The position peaked at $880K in Q1 2026. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

NBC Securities held 52,488 shares of Takeda Pharmaceutical worth $841K as of Q2 2026.
NBC Securities bought 4,955 Takeda Pharmaceutical shares in Q2 2026, an estimated $82K.
Takeda Pharmaceutical made up 0.06% of NBC Securities's portfolio in Q2 2026, its #352 holding.
NBC Securities first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 12 quarters since.
NBC Securities's Takeda Pharmaceutical position peaked at $880K in Q1 2026.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.